BREAKING: Indexes Mixed As Market Shrugs Off Inflation Data
Shares in DocuSign (DOCU) popped on Friday after it reported earnings and revenue that topped estimates amid sharply lowered expectations. DocuSign stock analysts debated the company’s turnaround plan from its new chief executive.
DocuSign stock rose 9.2% to 47.76 to in morning trading on the stock market today. Heading into the earnings report, shares were down 71% this year.
The San Francisco-based software maker cleared a low bar for the third quarter, Jefferies analyst Brent Thill said in a note to clients.
“(DocuSign) delivered a beat across the board against low expectations aided to some extent by early (contract) renewals,” Thill said. “Despite the beat, management’s billings growth outlook for fiscal 2024 is appropriately prudent given the tougher macro environment. (DocuSign) remains focused on improving its go-to-market motion, but it will take a few quarters.”
The maker of electronic signature software brought in a former Google executive, Allan Thygesen, as its new CEO in September. Former DocuSign CEO Dan Springer resigned in June following a string of disappointing earnings reports.
“While we await signs of improvement, we’re positive on the vision, including revamped go-to-market (digital self-serve, simplified product packaging, bolstered partner ecosystem, aligned sales incentives),” DocuSign stock analyst Rishi Jaluria from RBC Capital said in a note.
DocuSign earnings for the October-ending quarter came in at 57 cents a share, down 2% from a year earlier, but ahead of estimates for 42 cents.
Revenue rose 18% to $645 million. Analysts had predicted revenue of $627 million.
Sterling Auty, DocuSign stock analyst at MoffettNathanson, said the company’s turnaround will take time.
“DocuSign’s new CEO, Allan Thygesen, laid out several initiatives that were concrete and had legitimate specificity,” Auty said in his note.
“On fiscal 2024, preliminary commentary is for revenue growth in the high single digits — fine, consensus was at 9.6% prior so not too disappointing. Operating margins to be at the low-end of the 20- 25% range — also fine, maybe less exciting after the layoffs,” Auty went on to say.
He added: “The billings comments are not good. Not only because it was much further below consensus estimates for next year than the others. But also because of what it portends for the following year or years.”
Demand for DocuSign products surged during the early part of the coronavirus outbreak. But many businesses are resuming in-person meetings. The company’s software also automates the filing of contracts over the internet.
DocuSign stock owned a Relative Strength Rating of 10 out of a best-possible 99, according to IBD Stock Check-up.
Follow Reinhardt Krause on Twitter @reinhardtk_tech for updates on 5G wireless, artificial intelligence, cybersecurity and cloud computing.
YOU MIGHT ALSO LIKE:
How Digi International Used Acquisitions To Become A Player In The Internet Of Things
IBD Digital: Unlock IBD’s Premium Stock Lists, Tools And Analysis Today
Learn How To Time The Market With IBD’s ETF Market Strategy
IBD Live: A New Tool For Daily Stock Market Analysis
Want To Get Quick Profits And Avoid Big Losses? Try SwingTrader
5:53 AM ET The major stock market indexes were mixed after choppy trading. Medical stock gives back yesterday’s gains and then some.
5:53 AM ET The major stock market indexes were mixed after choppy trading….
(© Gary Neill)
Get instant access to exclusive stock lists, expert market analysis and powerful tools with 2 months of IBD Digital for only $20!
Get market updates, educational videos, webinars, and stock analysis.
Learn how you can make more money with IBD’s investing tools, top-performing stock lists, and educational content.
Notice: Information contained herein is not and should not be construed as an offer, solicitation, or recommendation to buy or sell securities. The information has been obtained from sources we believe to be reliable; however no guarantee is made or implied with respect to its accuracy, timeliness, or completeness. Authors may own the stocks they discuss. The information and content are subject to change without notice.
*Real-time prices by Nasdaq Last Sale. Realtime quote and/or trade prices are not sourced from all markets.
Ownership data provided by Refinitiv and Estimates data provided by FactSet.
© 2000-2022 Investor’s Business Daily, LLC. All rights reserved
